Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative change in medicine.
|
|
|
|
|
51-200 employees
View all Mauna Kea Technologies employees
|
|
|
Medical Equipment Manufacturing
|
|
|
24 Denby Road, Unit 140, Allston, MA 02134, US
|
|
|
2000
|
|
|
Medical Devices, Health, Healthcare, Research And Development, Ai, Medtech, Patient Outcomes, Patient Management, Early Detection, Cancer Imaging, Patient Centric, Endomicroscopy, In Vivo Microscopy, Cancer Detection, Cellvizio, Confocal Laser Endomicroscopy
|
Benjamin Abrat is the CEO of Mauna Kea Technologies. To contact Benjamin Abrat email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.